Benzinga's Volume Movers (THRX, TPCG, PRGS, ALXN)
Theravance Inc (NASDAQ: THRX) shares moved up 4.77% to $18.00 at 12:29 pm. The volume of THRX shares traded was 373% higher than normal. Theravance and GlaxoSmithKline Plc (NYSE: GSK) announced that their lung disease and asthma drug, Relovair has passed in a mid-stage safety study.
TPC Group Inc (NASDAQ: TPCG) shares rose 3.17% to $22.10. The volume of TPCG shares traded was 366% higher than normal. TPCG had started an offering of $325 million worth senior secured notes due 2017.
Progress Software Corp (NASDAQ: PRGS) shares climbed 6.54% to $31.92. The volume of PRGS shares traded was 261% higher than normal. PRGS had reported better-than-expected results for its FQ3.
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) shares gained 4.04% to $63.67. The volume of ALXN shares traded was 234% higher than normal. ALXN earnings are likely to gain 736.26% in this year.
Read more from Benzinga's Company news.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.